CFG
NVCR icon

Citizens Financial Group’s NovoCure NVCR Stock Holding History

Citizens Financial Group’s Portfolio NVCR Stock Details NVCR Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-34
Closed -$2K – 692
2020
Q2 		$2K Hold
34
– – ﹤0.01% 988
2020
Q1 		$2K Hold
34
– – ﹤0.01% 1024
2019
Q4 		$3K Buy
+34
New +$2.74K ﹤0.01% 934

Other funds holding NVCR

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
CS
Credit Suisse Zurich, Switzerland $104B AUM 34.76% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
DCP
Darsana Capital Partners New York $4.7B AUM 50.56% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Citizens Financial Group's NVCR Position: Q3 2020 in Review

Citizens Financial Group sold out of NovoCure (NVCR) in Q3 2020, closing a stake of 34 shares — an estimated $2K sold.

Citizens Financial Group first reported a position in NVCR in Q4 2019 and held it in 3 quarters. The position peaked at $3K in Q4 2019. 282 funds tracked by Wall St. Rank hold NVCR as of Q3 2020.

  • Citizens Financial Group reported no remaining NovoCure position as of Q3 2020 after selling out during the quarter.
  • Citizens Financial Group sold 34 NovoCure shares in Q3 2020, an estimated $2K.
  • Citizens Financial Group first reported a position in NovoCure in Q4 2019 and held it in 3 quarters.
  • Citizens Financial Group's NovoCure position peaked at $3K in Q4 2019.
  • 282 funds tracked by Wall St. Rank held NovoCure as of Q3 2020.

Based on Citizens Financial Group's 13F filing for Q3 2020, filed 12 Nov 2020.